A new biologic role for C3a and C3a desArg: Regulation of TNF-α and IL-1β synthesis

Journal of Immunology

Volumn 156, Issue 9, 1996, Pages 3455-3460

  Takabayashi, Tsukasa ^a,b   Vannier, Edouard ^a   Clark, Burton D ^a,b   Margolis, Nathan H ^a   Dinarello, Charles A ^a   Burke, John F ^b   Gelfand, Jeffrey A ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3A; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; GENE INDUCTION; HUMAN; HUMAN CELL; ISCHEMIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SYNTHESIS REGULATION; RNA ANALYSIS; SEPSIS; TISSUE INJURY;

CELL ADHESION; CELLS, CULTURED; COMPLEMENT C3A; HUMANS; INDOMETHACIN; INTERLEUKIN-1; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029974609     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Weinberg, P. F., M. A. Matthay, R. O. Webster, K. V. Roskos, I. M. Goldstein, and J. F. Murray. 1984. Biologically active products of complement and acute lung injury in patients with the sepsis syndrome. Am. Rev. Respir. Dis. 130:791.
2. Heideman, M., B. Norder-Hansson, A. Bengtson, and T. E. Mollnes. 1988. Terminal complement complexes and anaphylatoxins in septic and ischemic patients. Arch. Surg. 123:188.
3. Bengtson, A., and M. Heideman. 1988. Anaphylatoxin formation in sepsis. Arch. Surg. 123:645.
4. Hack, C. E., J. H. Nuijens, R. J. F. Felt-Bersma, W. O. Schreuder, A. J. M. Eerenberg-Belmer, J. Paardekooper, W. Bronsveld, and L. G. Thijs. 1989. Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis. Am. J. Med. 86:20.
5. Heideman, M., and T. E. Hugli. 1984. Anaphylatoxin generation in multisystem organ failure. J. Trauma 24:1038.
6. Zilow, G., T. Joka, U. Obertacke, U. Rother, and M. Kirschfink. 1992. Generation of anaphylatoxin C3a in plasma and bronchoalveolar lavage fluid in trauma patients at risk for adult respiratory distress syndrome. Crit. Care Med. 20:468.
7. Belmont, H. M., P. Hopkins, H. S. Edelson, H. B. Kaplan, R. Ludewig, G. Weissmann, and S. Abramson. 1986. Complement activation during systemic lupus erythematosus: C3a and C5a anaphylatoxins circulate during exacerbations of disease. Arthritis Rheum. 29:1085.
8. Goldstein, I. M. 1992. Complement: biologically active products. In Inflammation: Basic Principles and Clinical Correlates. J. I. Gallin, I. M. Goldstein, and R. Snyderman, eds. Raven Press, New York, p. 63.
9. Showell, H. J., M. M. Glovsky, and P. A. Ward. 1982. C3a-induced lysosomal enzyme secretion from human neutrophils: lack of inhibition by f-met-leu-phe antagonists and inhibition by arachidonic acid antagonists. Int. Arch. Allergy Appl. Immunol. 67:227.
10. Elsner, J., M. Oppermann, W. Czech, and A. Kapp. 1994. C3a activates the respiratory burst in human polymorphonuclear neutrophilic leukocytes via pertussis toxin-sensitive G-proteins. Blood 83:3324.
11. Morgan, E. L. 1987. The role of prostaglandins in C3a-mediated suppression of human in vitro polyclonal antibody responses. Clin. Immunol. Immunopathol. 44:1.
12. Beutler, B., and A. Cerami. 1986. Cachectin and tumor necrosis factor as two sides of the same biological coin. Nature 320:584.
13. Dinarello, C. A. 1991. Interleukin-1 and interleukin-1 antagonism. Blood 77: 1627.
14. Okusawa, S., C. A. Dinarello, K. B. Yancey, S. Endres, T. J. Lawley, M. M. Frank, J. F. Burke, and J. A. Gelfand. 1987. C5a induction of human interleukin 1: synergistic effect with endotoxin or interferon-y. J. Immunol. 139:2635.
15. Okusawa, S., K. B. Yancey, J. W. M. van der Meer, S. Endres, G. Lonnemann, K. Hefter, M. M. Frank, J. F. Burke, C. A. Dinarello, and J. A. Gelfand. 1988. C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro: comparison with secretion of interleukin 1β and interleukin 1α. J. Exp. Med. 168:443.
16. Schindler, R., J. A. Gelfand, and C. A. Dinarello. 1990. Recombinant C5a stimulates transcription rather than translation of interleukin-1 (IL-1) and tumor necrosis factor: translational signal provided by lipopolysaccharide or IL-1 itself. Blood 76:1631.
17. Haeffner-Cavaillon, N., J. M. Cavaillon, M. Laude, and M. D. Kazatchkine. 1987. C3a (C3a des-Arg) induces production and release of interleukin 1 by cultured human monocytes. J. Immunol. 139:794.
18. Arend, W. P., R. J. Massoni, M. A. Niemann, and P. C. Giclas. 1989. Absence of induction of IL-1 production in human monocytes by complement fragments. J. Immunol. 142:173.
19. Luger, A., H. Graf, H. P. Schwarz, H. K. Stummvoll, and T. A. Luger. 1986. Decreased serum interleukin 1 activity and monocyte interleukin 1 production in patients with fatal sepsis. Crit. Care Med. 14:458.
20. Fernandez, H. N., and T. E. Hugli. 1976. Partial characterization of human C5a anaphylatoxin. I. Chemical description of the carbohydrate and polypeptide portions of human C5a. J. Immunol. 117:1688.
21. Fukuoka, Y., and T. E. Hugli. 1988. Demonstration of a specific C3a receptor on guinea pig platelets. J. Immunol. 140:3496.
22. Schindler, R., and C. A. Dinarello. 1990. Ultrafiltration to remove endotoxins and other cytokine-inducing materials from tissue culture media and parenteral fluids. Biotechniques 8:408.
23. Kunkel, S. L., S. W. Chensue, and S. H. Phan. 1986. Prostaglandins as endogenous mediators of interleukin 1 production. J. Immunol. 136:186.
24. 2 regulates macrophage-derived tumor necrosis factor gene expression. J. Biol. Chem. 263:5380.
25. Muegge, K., and S. K. Durum. 1991. Measurement of soluble and membrane-bound interleukin 1. In Current Protocols in Immunology. J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds. John Wiley & Sons, New York, p. 6.2.1.
26. Haskill, S., C. Johnson, D. Eierman, S. Becker, and K. Warren. 1988. Adherence induces selective mRNA expression of monocyte mediators and proto-oncogenes. J. Immunol. 140:1690.
27. Schindler, R., B. D. Clark, and C. A. Dinarello. 1990. Dissociation between interleukin-1β mRNA and protein synthesis in human peripheral blood mononuclear cells. J. Biol. Chem. 265:10232.
28. Quezado, Z. M. N., W. D. Hoffman, J. A. Winkelstein, I. Yatsiv, C. A. Koev, L. C. Cork, R. J. Elin, P. Q. Eichacker, and C. Natanson. 1994. The third component of complement protects against Escherichia coli endotoxin-induced shock and multiple organ failure. J. Exp. Med. 179:569.
29. Osborn, L. 1990. Leukocyte adhesion to endothelium in inflammation. Cell 62:3.
30. Doherty, D. E., C. Haslett, M. G. Tonnesen, and P. M. Henson. 1987. Human monocyte adherence: a primary effect of chemotactic factors on the monocyte to stimulate adherence to human endothelium. J. Immunol. 138:1762.
31. Juliano, R. L., and S. Haskill. 1993. Signal transduction from the extracellular matrix. J. Cell Biol. 120:577.
32. Bokisch, V. A., and H. J. Muller-Eberhard. 1970. Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase. J. Clin. Invest. 49:2427.
33. Charriaut, C., A. Senik, J. P. Kolb, M. Barel, and R. Frade. 1982. Inhibition of in vitro natural killer activity by the third component of complement: role for the C3a fragment. Proc. Natl. Acad. Sci. USA 79:6003.
34. Polley, M. J., and R. L. Nachman. 1983. Human platelet activation by C3a and C3a des-Arg. J. Exp. Med. 158:603.
35. Fukuoka, Y., and T. E. Hugli. 1990. Anaphylatoxin binding and degradation by rat peritoneal mast cells: mechanisms of degranulation and control. J. Immunol. 145:1851.
36. Baldo, A., A. D. Sniderman, S. St-Luce, R. K. Avramoglu, M. Maslowska, B. Hoang, J. C. Monge, A. Bell, S. Mulay, and K. Cianflone. 1993. The adipsinacylation stimulating protein system and regulation of intracellular triglyceride synthesis. J. Clin. Invest. 92:1543.